“…Emerging clinical tools by quantitative echocardiography, measuring absolute AR-degree (RVol or ERO) and total LV consequences of AR (LV volumes) raised new hopes. These tools were developed in physiologic studies (18,24,28), codified by guidelines of the American Society of Echocardiography (10,15), and endorsed by major American and European cardiac societies, but their impact on clinical outcome was unknown. In view of insensitivity and prognostic inferiority of traditional tools (LV diameters) for detecting high-risk patients (6), the present data are essential in managing asymptomatic patients with AR and preserved EF, among which high-risk subsets can now be identified and aggressively managed.…”